These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Levofloxacin: penetration into sputum and once-daily treatment of respiratory tract infections. Nakamori Y; Miyashita Y; Nakatani I; Nakata K Drugs; 1995; 49 Suppl 2():418-9. PubMed ID: 8549384 [No Abstract] [Full Text] [Related]
4. A comparative study of ofloxacin twice and three times daily in the treatment of respiratory tract infections. Sawae Y; Ninomiya K; Takaki K; Shimono N; Misumi H; Okada K Drugs; 1995; 49 Suppl 2():430-2. PubMed ID: 8549390 [No Abstract] [Full Text] [Related]
5. Clinical efficacy of levofloxacin in elderly patients with respiratory tract infections. Sato A; Ogawa H; Iwata M; Ono T; Yasuda K; Nagayama M; Shirai T; Shirai M; Ida M; Suda T Drugs; 1995; 49 Suppl 2():428-9. PubMed ID: 8549388 [No Abstract] [Full Text] [Related]
6. [Levofloxacin in the treatment of respiratory infections]. Iakovlev SV; Iakovlev VP Antibiot Khimioter; 2002; 47(8):32-42. PubMed ID: 12515095 [No Abstract] [Full Text] [Related]
7. Levofloxacin in patients with severe respiratory tract infection. Odagiri S Drugs; 1995; 49 Suppl 2():426-7. PubMed ID: 8549387 [No Abstract] [Full Text] [Related]
8. [Observational study investigating the use of levofloxacin in ICU patients]. Alvarez-Lerma F; Palomar M; Olaechea P; León C; Sánchez M; Bermejo B; Enferm Infecc Microbiol Clin; 2004 Apr; 22(4):220-6. PubMed ID: 15056438 [TBL] [Abstract][Full Text] [Related]
9. [The first 'respiration' fluoroquinolone--levofloxacin (Tavanic) in therapy of bacterial infections. Pharmacodynamics principles in optimization of administration regimens]. Budanov SV; Vasil'ev AN; Smirnova LB Antibiot Khimioter; 2001; 46(7):38-46. PubMed ID: 11697244 [No Abstract] [Full Text] [Related]
10. Inhibitory effect of ofloxacin on acute exacerbations of chronic respiratory tract infections in comparison with erythromycin. Kawahara S; Watanabe Y; Matsuka Y; Sato T; Takahashi K Drugs; 1995; 49 Suppl 2():414-5. PubMed ID: 8549382 [No Abstract] [Full Text] [Related]
11. Clinical efficacy of ofloxacin in acute exacerbations of chronic respiratory disease. Watanabe K; Yoshida M; Ishibashi T; Yamada H; Kido M; Hirose T; Maeda F; Matsuzaki Y Drugs; 1995; 49 Suppl 2():448-50. PubMed ID: 8549396 [No Abstract] [Full Text] [Related]
12. [The present and future of levofloxacin in the treatment of respiratory infections]. García-Rodríguez JA; Muñoz Bellido JL; Alonso Manzanares MA; Gutiérrez Zufiaurre MN Enferm Infecc Microbiol Clin; 1999; 17 Suppl 1():53-8. PubMed ID: 10563113 [No Abstract] [Full Text] [Related]
13. Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract. Langtry HD; Lamb HM Drugs; 1998 Sep; 56(3):487-515. PubMed ID: 9777318 [TBL] [Abstract][Full Text] [Related]
14. Role of levofloxacin in the treatment of lower respiratory tract infections (LRTIs). Blasi F J Chemother; 2004 Apr; 16 Suppl 2():11-4. PubMed ID: 15255556 [No Abstract] [Full Text] [Related]
15. The influence of comorbidity on the effect of levofloxacin treatment success of ambulatory respiratory tract infections. Burgmann H; Mayer B; Lukas A; Kumbein F; Oberbauer R Wien Med Wochenschr; 2003; 153(7-8):156-62. PubMed ID: 12764869 [TBL] [Abstract][Full Text] [Related]
16. Intravenous followed by oral ofloxacin in the treatment of community acquired lower respiratory tract infections in adults requiring hospitalisation. Liam CK; Aziah AM; Lim KH; Wong CM Med J Malaysia; 2000 Sep; 55(3):304-7. PubMed ID: 11200708 [TBL] [Abstract][Full Text] [Related]
17. Criteria for use of ofloxacin and lomefloxacin in adult inpatients and outpatients. Spivey IM Clin Pharm; 1993 Jun; 12(6):452-8. PubMed ID: 8403817 [No Abstract] [Full Text] [Related]
18. A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis. Schwab IR; Friedlaender M; McCulley J; Lichtenstein SJ; Moran CT; Ophthalmology; 2003 Mar; 110(3):457-65. PubMed ID: 12623805 [TBL] [Abstract][Full Text] [Related]
19. [Multicentric study for evaluation of levofloxacin in the treatment of complicated urinary tract infections]. Trinchieri A; Marchetti F Arch Ital Urol Androl; 2003 Mar; 75(1):49-52. PubMed ID: 12741347 [TBL] [Abstract][Full Text] [Related]
20. [Treatment in general practice. Effective, well tolerated therapy]. MMW Fortschr Med; 2000 Sep; 142(37):58-9. PubMed ID: 11026226 [No Abstract] [Full Text] [Related] [Next] [New Search]